Tag Archives: Pittsburgh Compound B (PIB-PET)

More on the Cognitive Reserve Hypothesis (BBC News / Nature Neuroscience)

Summary A small study based at the University of California suggests some people’s brains may have the ability to resist early damage arising in the initial stages of Alzheimer’s Disease. In elderly subjects asked to memorise a series of pictures … Continue reading

Posted in BBC News, For Doctors (mostly), For Researchers (mostly), In the News, International, Quick Insights, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Miscellaneous Dementia-Related Systematic Reviews and Meta-Analyses

Summary Recent reviews and meta-analyses are listed below. Some of these articles may be available freely (according to local circumstances). A suitable Athens password, a journal subscription or payment for access may be required to obtain the full-text of the … Continue reading

Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Systematic Reviews | Tagged , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Bapineuzumab Trials Results in Mild-to-Moderate Alzheimer’s Disease (New England Journal of Medicine)

Summary Bapineuzumab is an anti-amyloid-beta monoclonal antibody, which had shown promise for the treatment of Alzheimer’s Disease. Two double-blind, randomised, placebo-controlled, phase 3 trials have been conducted, involving 2204 patients with mild-to-moderate Alzheimer’s disease. One trial involved 1121 carriers of … Continue reading

Posted in For Doctors (mostly), For Researchers (mostly), International, Pharmacological Treatments | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment